Table 3.
New Diagnoses Identified in Participants Through Their Medical Records Within 30 Days Post–Symptom Onset (or Enrollment if No Symptom Onset Date Was Identified)
| Inpatient, SARS-CoV-2 Negative (n=30), No. (%) | Inpatient, SARS-CoV-2 Positive (n=212), No. (%) | Outpatient, SARS-CoV-2 Negative (n=88), No. (%) | Outpatient, SARS-CoV-2 Positive (n=838), No. (%) | |
|---|---|---|---|---|
| Pulmonary | ||||
| Viral pneumonia | 4 (13.3) | 148 (69.8) | 2 (2.3) | 23 (2.7) |
| Unspecified pneumonia | 9 (30.0) | 53 (25.0) | 3 (3.4) | 14 (1.7) |
| ARDS | 0 (0.0) | 19 (9.0) | 0 (0.0) | 0 (0.0) |
| Bacterial pneumonia | 2 (6.7) | 14 (6.6) | 0 (0.0) | 0 (0.0) |
| Asthma | 5 (16.7) | 5 (2.4) | 0 (0.0) | 3 (0.4) |
| Obstructive lung disease | 1 (3.3) | 5 (2.4) | 1 (1.1) | 2 (0.2) |
| Restrictive lung disease | 1 (3.3) | 7 (3.3) | 0 (0.0) | 1 (0.1) |
| Pneumothorax | 0 (0.0) | 3 (1.4) | 0 (0.0) | 0 (0.0) |
| Cardiovascular | ||||
| Hypertension | 6 (20.0) | 26 (12.3) | 2 (2.3) | 10 (1.2) |
| Pulmonary embolism/DVT | 1 (3.3) | 14 (6.6) | 0 (0.0) | 1 (0.1) |
| Ischemic heart disease | 3 (10.0) | 13 (6.1) | 1 (1.1) | 5 (0.6) |
| Cardiac arrest | 0 (0.0) | 6 (2.8) | 0 (0.0) | 0 (0.0) |
| Heart failure | 2 (6.7) | 5 (2.4) | 0 (0.0) | 1 (0.1) |
| Myocarditis | 1 (3.3) | 5 (2.4) | 0 (0.0) | 1 (0.1) |
| Atrial fibrillation | 2 (6.7) | 5 (2.4) | 0 (0.0) | 0 (0.0) |
| Cardiomyopathy | 0 (0.0) | 2 (0.9) | 0 (0.0) | 0 (0.0) |
| Cerebrovascular disease | 0 (0.0) | 2 (0.9) | 0 (0.0) | 0 (0.0) |
| Neurology | ||||
| Headache | 1 (3.3) | 12 (5.7) | 3 (3.4) | 6 (0.7) |
| Pain syndrome | 0 (0.0) | 10 (4.7) | 1 (1.1) | 1 (0.1) |
| Sleep disorders | 2 (6.7) | 10 (4.7) | 0 (0.0) | 4 (0.5) |
| Postviral fatigue/encephalopathy | 0 (0.0) | 7 (3.3) | 0 (0.0) | 0 (0.0) |
| Neuropathies | 1 (3.3) | 3 (1.4) | 0 (0.0) | 1 (0.1) |
| Meningitis/encephalitis | 0 (0.0) | 2 (0.9) | 0 (0.0) | 0 (0.0) |
| Movement disorders | 0 (0.0) | 1 (0.5) | 0 (0.0) | 0 (0.0) |
| Other acute central nervous system signs and symptoms | 1 (3.3) | 15 (7.1) | 1 (1.1) | 28 (3.3) |
| Mental health | ||||
| Anxiety somatoform disorders | 3 (10.0) | 15 (7.1) | 0 (0.0) | 9 (1.1) |
| Depression | 1 (3.3) | 11 (5.2) | 0 (0.0) | 4 (0.5) |
| Endocrine | ||||
| Diabetes | 1 (3.3) | 11 (5.2) | 2 (2.3) | 3 (0.4) |
| Liver | ||||
| Chronic liver disease | 3 (10.0) | 15 (7.1) | 0 (0.0) | 1 (0.1) |
| Renal | ||||
| Acute kidney injury | 7 (23.3) | 32 (15.1) | 0 (0.0) | 3 (0.4) |
| Chronic kidney disease | 2 (6.7) | 10 (4.7) | 1 (1.1) | 2 (0.2) |
| Other | ||||
| Bacteremia | 4 (13.3) | 5 (2.4) | 0 (0.0) | 1 (0.1) |
| DIC/coagulopathy | 1 (3.3) | 5 (2.4) | 0 (0.0) | 0 (0.0) |
Abbreviations: ARDS, acute respiratory distress syndrome; DIC, disseminated intravascular coagulation; DVT, deep vein thrombosis; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.